Abstract
Objective: RNAe is a new method that enhances protein expression at the post-transcriptional level. RNAe utility was further explored to improve endogenous protein expression. Results: Transgenic mice were created by targeting RNAe to growth hormone gene into the C57/BL mouse genome by transposon mediated integration; the mice showed a heavier body weight and longer body length compared with normal mice. RNAe can also be used for gene therapy through the delivery of in vitro transcribed RNA. Conclusion: This study takes a further step towards applying RNAe in pharmaceutical approaches by transposon-based transgenic mice model construction and the use of in vitro transcribed RNA transfection assay.
| Original language | English |
|---|---|
| Pages (from-to) | 179-188 |
| Number of pages | 10 |
| Journal | Biotechnology Letters |
| Volume | 39 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Feb 2017 |
| Externally published | Yes |
Keywords
- Growth hormone
- Pharmaceutical application
- Protein production
- RNAe
- Transgenic mice
Fingerprint
Dive into the research topics of 'RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver